Through a collaboration with Edwards Lifesciences, Philips is rolling out new artificial intelligence tools designed to ...

Genmab has shed another antibody-drug conjugate from its April 2024 acquisition of ProfoundBio. | Genmab has shed another ...

After laying off most of its staff and partnering away its phase 3 cancer asset earlier this year, precision oncology outfit ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes ...

Amid its multi-front legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ...

Bayer has built a home for Chinese biopharma companies. Located in Beijing, the Bayer E-Town Open Innovation Center will ...

Nxera Pharma has outlined plans to lay off 15% of its staff and prioritize its pipeline as part of a push to clear its path ...

Beacon Biosignals, known for its sleep monitoring system, hauled in $86 million as part of an oversubscribed series B funding ...

Genetic medicines-focused Scribe Therapeutics is racing toward the clinic on the heels of a preclinical data drop for three ...

Artios Pharma collected $115 million from an oversubscribed series D that will support its growing ambitions for its pipeline ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with ...